On the physiological role(s) of the paraoxonases

Chemico-Biological Interactions

Volumn 119-120, Issue , 1999, Pages 379-388

  La Du, Bert N ^a   Aviram, Michael ^b   Billecke, Scott ^a   Navab, Mohamad ^c   Primo Parmo, Sergio ^a   Sorenson, Robert C ^a   Standiford, Theodore J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b RAMBAM MEDICAL CENTER   (Israel)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bacterial endotoxin; HDL; LDL; Paraoxonases; PON evolution; PON polymorphisms; PON1 mutants

Indexed keywords

ARYLDIALKYLPHOSPHATASE; BACTERIUM LIPOPOLYSACCHARIDE; CALCIUM; ENDOTOXIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; NEUROTOXIN; ORGANOPHOSPHATE INSECTICIDE; ORGANOPHOSPHORUS COMPOUND; PARAOXON;

AMINO ACID SEQUENCE; ATHEROSCLEROSIS; CATALYSIS; CONFERENCE PAPER; ENDOTOXEMIA; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME POLYMORPHISM; ENZYME SPECIFICITY; ENZYME STRUCTURE; HUMAN; LIPID OXIDATION; MOUSE; MUTANT; NONHUMAN; PROTECTION;

AMINO ACID SEQUENCE; ANIMALS; ARYLDIALKYLPHOSPHATASE; BACTERIAL TOXINS; ESTERASES; HUMANS; LIPOPROTEINS, LDL; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION; PHOSPHORIC ACID ESTERS; SEQUENCE HOMOLOGY, AMINO ACID;

BACTERIA (MICROORGANISMS); MAMMALIA;

EID: 0033002909     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(99)00049-6     Document Type: Conference Paper

References (17)

1. Augustinsson K.B. The evolution of esterases. van Thoai N., Roche J. Homologous Enzymes and Biochemical Evolution, Gordon and Breach, New York. 1968;299-311.
2. Primo-Parmo S.L., Sorenson R.C., Teiber J., La Du B.N. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics. 33:1996;498-507.
3. Shih D.M., Gu L., Xia Y.-R., Navab M., Li W.-F., Hama S., Castellani L.W., Furlong C.E., Costa L.G., Fogelman A.M., Lusis A.J. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature. 394:1998;284-287.
4. Mahmood N.A., Carmichael W.W. The pharmacology of anatoxin-a(s), neurotoxin produced by the freshwater cyanobacterium Anabaena flos-aquae NRC 525-17. Toxicon. 24:1986;425-434.
5. Mackness M.I. Commentary A-esterases: enzymes looking for a role? Biochem. Pharmacol. 38:1989;385-390.
6. Watson A.D., Berliner J.A., Hama S.Y., La Du B.N., Faull K.F., Fogelman A.M., Navab M. Protective effect of HDL associated paraoxonase-inhibition of the biological activity of minimally oxidized low density lipoprotein. J. Clin. Invest. 96:1995;2882-2891.
7. Aviram M., Rosenblat M., Bisgaier C.L., Newton R.S., Primo-Parmo S.L., La Du B.N. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J. Clin. Invest. 101:1998;1581-1590.
8. Aviram M., Billecke S., Sorenson R., Bisgaier C., Newton R., Rosenblat M., Erogul J., Hsu C., Dunlop C., La Du B. Paraoxonase active site required against LDL oxidation involves its free sulfhydryl group and is different than that irequired for its arylesterase/paraoxonase activities: selective action for human paraoxonase allozymes Q and R. Arterioscler. Thromb. Vasc. Biol. 18:1998;1617-1624.
9. Sorenson R.C., Primo-Parmo S.L., Kuo C-L., Adkins S., Lockridge O., La Du B.N. Reconsideration of the catalytic center and mechanism of mammalian paraoxonase/arylesterase. Proc. Natl. Acad. Sci. USA. 92:1995;7187-7191.
10. Mackness M.I., Arrol S., Mackness B., Durrington P.N. Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidation. Lancet. 349:1997;851-852.
11. M. Aviram, M. Rosenblat, S. Billecke, J. Erogul, R. Sorenson, C.L.Bisgaier, R. Newton, B. La Du, Human serum paraoxonase (PON1) inactivation by oxidized low density lipoprotein: Role for PON's free sulfhydryl group and effect of antioxidants. Free Radic. Biol. Med. in press.
12. Levine D.M., Parker T.S., Donnelly T.M., Walsh A., Rubin A.L. In vivo protection against endotoxin by plasma high density lipoprotein. Proc. Nat. Acad. Sci. USA. 90:1993;12040-12044.
13. Johnson K.J., Ward P.A., Gorainick S., Osborn M.J. Isolation from human serum of an inactivator of bacterial lipopolysaccharide. Am. J. Pathol. 88:1977;559-574.
14. Gu G., Caldwell G.A., Chalfie M. Genetic interactions affecting touch sensitivity in Caenorhabditis elegans. Proc. Nat. Acad. Sci. USA. 93:1996;6577-6582.
15. 2-binding proteins isolated from squid optic lobe by phenothiazine-sepharose affinity chromatography. Biochem. J. 209:1983;797-802.
16. Tougou K., Nakamura A., Watanabe S., Okuyama Y., Morino A. Paraoxonase has a major role in the hydrolysis of prulifloxacin (NM441), a prodrug of a new antibacterial agent. Drug Metab. Dispo. 26:1998;355-359.
17. R.C. Sorenson, M. Aviram, C.L. Bisgaier, S. Billecke, C. Hsu, B.N. La Du, Properties of the retained N-terminal hydrophobic leader sequence in human serum paraoxonase/arylesterase. Chem.-Biol. Interact. 119-120 (1999) 243-249.